COVID-19 Clinical Trials in Communities of Color
Tuesday, Dec. 8
1 p.m. ET/10 a.m. PT
This webinar is a part of a series on COVID-19 and is provided in partnership with the COVID-19 Prevention Network (CoVPN). Join us to learn about the community-level considerations associated with engaging Black/African American, Latinx and Native/Indigenous populations in COVID-19 clinical trials. The panelists will also highlight successful engagement strategies and key clinical/research considerations that may help support successful patient referrals. Finally, the panelists will discuss what is needed to support acceptability and uptake of an approved COVID-19 vaccine in these populations. 

The panel includes:

Martez D.R. Smith, LMSW
Provost’s Fellow and a doctoral candidate at the University of Rochester School of Nursing

Valeria Cantos, MD
Assistant Professor at the Division of Infectious Diseases at Emory University

Bonnie Duran, DrPH
Professor in the Schools of Social Work and Public Health at the University of Washington

Sheldon D. Fields, PhD, RN, FNP-BC, AACRN, FAANP, FNAP, FAAN
Associate Dean for Equity & Inclusion, Penn State College of Nursing
1st Vice President, National Black Nurses Association, Inc.

Stephaun E. Wallace, PhD, MS
Director of External Relations, COVID-19 Prevention Network and Staff Scientist, Vaccine and Infectious Disease Division, Fred Hutch 
 
By the end of the presentation, participants will be able to:
  • Explain the impact of social determinants of health and health equity on COVID-19 and the COVID-19 vaccine
  • Compare and contrast COVID-19 vaccine preparedness, barriers and dissemination in disproportionately impacted communities
  • Describe the importance of diversity in clinical trials

 
After registering, you will receive a confirmation email containing information about joining the webinar. 
 
ANAC will provide 1.0 contact hour of CNE for the successful completion of this event.
The COVID-19 Prevention Network (CoVPN) was formed by the National Institute of Allergy and Infectious Diseases (NIAID) at the US National Institutes of Health to respond to the global pandemic. The CoVPN was formed through a parnertship between HIV Vaccine Trials Network, HIV Prevention Trials Network, Infectious Disease Clinical Research Consortium and AIDS Clinical Trials Group. Learn more about CoVPN. 

The Association of Nurses in AIDS Care (ANAC) is accredited as a provider of 
nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.